Table 3. Detection of PIK3CA-H1047R and KRAS-G12D in cfDNA.
Sample number (n=29) | PIK3CA-H1047R | KRAS-G12D | |||
---|---|---|---|---|---|
Stage | Tumor | cfDNA (copies/ml) | Tumor | cfDNA (copies/ml) | |
OCCC1 | III | ||||
OCCC2 | I | ||||
OCCC3 | I | ||||
OCCC4 | I | • | 0 | ||
OCCC5 | I | ||||
OCCC6 | I | ||||
OCCC8 | III | ||||
OCCC10 | III | ||||
OCCC11 | II | ||||
OCCC12 | I | • | 0 | ||
OCCC13 | IV | • | 165 | ||
OCCC14 | III | • | 285 | ||
OCCC15 | III | ||||
OCCC16 | I | ||||
OCCC17 | I | • | 275 | ||
OCCC18 | I | ||||
OCCC19 | I | ||||
OCCC21 | I | • | 0 | ||
OCCC22 | I | ||||
OCCC24 | I | ||||
OCCC25 | II | • | 0* | ||
OCCC26 | I | ||||
OCCC27 | I | • | 0 | ||
OCCC31 | I | ||||
OCCC33 | I | ||||
OCCC34 | III | ||||
OCCC35 | I | ||||
OCCC36 | I | ||||
OCCC37 | II |
*Although cfDNA was 0 at the initial diagnosis, cfDNA was detected during the course of disease.